DSS, INC. (DSS) Profit Breakdown
- 2026-06-30: Securities -$840.00K; Product Packaging -$83.00K; Commercial Banking $6.00K; Biotechnology $2.00K.
- 2025-06-30: Securities -$184.00K; Product Packaging $194.00K; Commercial Banking -$225.00K; Biotechnology $4.00K.
Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.
- Available history
- 2010-06-30 to 2026-06-30
- Data captured
Profit by product
Gross profit: each quarter (3 month)
| Quarter end | Securities | Product Packaging | Commercial Banking | Biotechnology |
|---|
| 2026-06-30 | -$840.00K | -$83.00K | $6.00K | $2.00K |
|---|
| 2025-06-30 | -$184.00K | $194.00K | -$225.00K | $4.00K |
|---|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest: each quarter (3 month)
| Quarter end | Securities | Product Packaging | Commercial Banking | Biotechnology |
|---|
| 2026-06-30 | -$1.38M | -$984.00K | -$51.00K | -$695.00K |
|---|
| 2025-06-30 | -$814.00K | -$597.00K | -$470.00K | -$1.19M |
|---|
Operating income: each quarter (3 month)
| Quarter end | Securities | Product Packaging | Commercial Banking | Biotechnology |
|---|
| 2026-06-30 | -$1.17M | -$956.00K | -$88.00K | -$697.00K |
|---|
| 2025-06-30 | -$921.00K | -$560.00K | -$300.00K | -$1.19M |
|---|